We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
    • Leafly.deGerman flag
  • Help
  • News
  • Lifestyle
  • Strains & products
  • Industry
  • Growing
  • Health
  • Science & tech
  • Leafly USA
  • Podcasts
  • Learn
Politics

Maryland Governor Orders Diversity Study of Medical Cannabis Industry

The Associated PressPublished on April 27, 2017 · Last updated July 28, 2020
Maryland Gov. Larry Hogan speaks at a news conference outside the Maryland State House on the final day of the state's legislative session in Annapolis, Md., Monday, April 10, 2017. (AP Photo/Patrick Semansky)

ANNAPOLIS, Md. (AP) — Maryland Gov. Larry Hogan on Thursday ordered a study of the state’s developing medical marijuana industry to ensure opportunities for minority participation.

Hogan directed the Governor’s Office of Minority Affairs to initiate a disparity study. He instructed the office to work together with the state’s medical cannabis commission and the transportation department.

“As the issue of promoting diversity is of great importance to me and my administration, your office should begin this process immediately in order to ensure opportunities for minority participation in the industry,” Hogan wrote to Jimmy Rhee, the head of the minority affairs office.

The Republican governor ordered the study in response to concerns expressed by the Legislative Black Caucus of Maryland. Legislation that would have created more licenses to grow cannabis to address a lack of minority ownership after a disparity study is conducted failed to pass in the closing minutes of the legislative session that ended this month.

Leaders of the black caucus have called for a special session to pass the bill, which they say was on the verge of passing as the clock struck midnight and ended the 90-day session before a final vote could be taken.

Differences between the House and Senate slowed the measure’s movement. A House bill would have added five licenses to the 15 currently allowed to grow cannabis. Those additional licenses would have been available to minority-owned companies after a disparity study. A Senate bill also would have added licenses. It differed from the House bill by allowing two companies that were bumped out of the top 15 businesses that were initially named as finalists. The commission said the juggling was needed to create geographic diversity of grower locations. The two companies that were knocked out are suing the state.

Maryland’s medical marijuana rollout has been delayed by setbacks over the years. The state approved its first medical cannabis law in 2013. The effort stalled, however, because it required academic medical centers to run the programs, and none stepped forward. The law was changed in 2014 to allow doctors certified by a state commission to recommend cannabis for patients with debilitating, chronic and severe illnesses.

Companies have shown strong interest in Maryland, because the market is expected to be lucrative. Marijuana will be available for any condition that is severe in which other medical treatments have been ineffective. Nurse practitioners, dentists, podiatrists and nurse midwives will be able to recommend its use, as well as doctors.

Business interest also has been stoked by potential legalization of recreational cannabis down the road. No final licenses have been awarded yet.

Related Coverage

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
diversitylegislationlicensingmarylandmedical marijuana
The Associated Press
The Associated Press
The AP is one of the world's largest and most trusted sources of independent newsgathering.
View The Associated Press's articles

The latest in Politics

  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
  • Analysis: Don’t hold your breath for legalization under Trump 2.0 image
    Analysis: Don’t hold your breath for legalization under Trump 2.0
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.